DTIL - Rasio kapitalisasi pasar marang pendapatan precisionbiosciences.com
The resilience of the Precision BioSciences (DTIL) model is based on the automation of gene editing via AI systems. The ratio of trading value to revenue visualizes this trend, where 4.90 shows the current value of the metric. High precision in DNA modifications reduces mutation risks, while stringent FDA requirements and patent protection create a powerful barrier for new entrants in the biomedicine sector.
Rincian metrik lan analitis perusahaan Precision BioSciences (DTIL)
- rega saham lan target rega konsensus:
- statistik kapitalisasi pasar:
- indikator kapitalisasi buku:
- statistik kawajiban utang lan likuiditas:
Utang marang Modal Precision BioSciences|DTIL - Utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal precisionbiosciences.com|DTIL - Gunggung utang perusahaan|Utang marang nilai buku Precision BioSciences|DTIL - Utang jangka dawa perusahaan|Gunggunge utang jangka cendhak Precision BioSciences|Likuiditas darurat precisionbiosciences.com
- rincian asil keuangan lan kelipatan valuasi:
DTIL - Bathi resik perusahaan|Prakiraan bathi resik Precision BioSciences|DTIL - Pangali P/E|Prakiraan rega marang bathi Precision BioSciences Inc.|DTIL - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Precision BioSciences|DTIL - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi resik saben saham sajrone patang kuartal pungkasan Precision BioSciences|DTIL - Bathi resik saben saham (EPS TTM)|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan precisionbiosciences.com|DTIL - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep Precision BioSciences
- rincian pendapatan lan dodolan emiten:
Analisis umum perusahaan:DTIL (Precision BioSciences Inc.)
For Precision BioSciences (DTIL), whose biotechnological developments are isolated from macroeconomic fluctuations, the P/S ratio serves as a key tool for assessing market value. This metric is calculated as the ratio of market capitalization to annual revenue, determining the value of each dollar of sales. By analyzing the price/sales multiple, an investor can identify phases of asset overheating or undervaluation. Stable demand for drugs makes this indicator a reliable filter for long-term planning.
Perusahaan pesaing
Tempus AI - Rasio kapitalisasi marang pendapatan|Qiagen - Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan IONS|Repligen Corp. - Multiplikator P/S|RNA: Rasio rega marang pendapatan|CRSP: Multiplikator P/S|WGS - Koefisien rega marang pendapatan|Rasio rega marang pendapatan Ultragenyx|Rega marang dodolan Beam Therapeutics Inc BEAM|Rasio rega marang pendapatan Sarepta Therapeutics Inc (SRPT)|Koefisien rega marang pendapatan Twist Bioscience Corp|Multiplikator P/S TXG (10x Genomics, Inc.)|NTLA - Kapitalisasi marang pendapatan|Stoke Therapeutics, Inc. - Multiplikator P/S|Koefisien rega marang pendapatan BioLife Solutions Inc BLFS|WVE: Multiplikator P/S|Rega marang dodolan Maze Therapeutics Corp (MAZE)|Rasio rega marang pendapatan Sionna Therapeutics Inc|Rasio kapitalisasi marang pendapatan PRME (primemedicine.com)|Multiplikator P/S TSHA|Kapitalisasi marang pendapatan uniQure NV QURE|Multiplikator P/S MGTX (MeiraGTx PLC)|REGENXBIO Corp (RGNX) - Rega marang dodolan|SLDB - Rasio rega marang pendapatan|Koefisien rega marang pendapatan ocugen.com OCGN|PACB: Multiplikator P/S|Rasio kapitalisasi marang pendapatan BNTC|Kapitalisasi marang pendapatan DSGN|RCKT (Rocket Corp) - Kapitalisasi marang volume dodolan|Multiplikator P/S FDMT|Koefisien rega marang pendapatan lexeotx.com|Rasio rega marang pendapatan Korro Bio KRRO|Editas Medicine Inc - Rasio rega marang pendapatan|Silence Therapeutics Inc. - Multiplikator P/S|PRQR (ProQR Therapeutics N.V.) - Rasio kapitalisasi marang pendapatan|codexis.com (CDXS) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan SGMO|NAUT (Nautilus Biotechnology, Inc.) - Multiplikator P/S|Multiplikator P/S Metagenomi Inc.|Rasio rega marang pendapatan Generation Bio Co. (GBIO)|BOLD: Rasio rega marang dodolan|Rasio rega marang pendapatan Exicure XCUR|Rasio kapitalisasi pasar marang pendapatan IMNN|RXi Pharmaceuticals - Multiplikator P/S|Rega marang dodolan Mustang Bio, Inc.|RNAZ: Multiplikator P/S|Kapitalisasi marang pendapatan Bionano Genomics|APDN (Applied DNA Sciences) - Multiplikator P/S|bluebirdbio.com (BLUE) - Koefisien rega marang pendapatan|Rasio rega marang pendapatan ImmunoPrecise Antibodies (IPA)|Koefisien rega marang pendapatan Omega Therapeutics Inc|Multiplikator P/S OMIC (Singular Genomics Systems Inc)|Koefisien rega marang pendapatan Regulus (RGLS)|SYRS - Rasio rega marang pendapatan|Rega marang dodolan telesisbio.com|TRACON Pharmaceuticals, Inc. (TCON) - Rasio rega marang pendapatan|Rasio kapitalisasi marang pendapatan UBX
